UPC
Universe Pharmaceuticals INCCompany with tickers: UPC
CIK
1809616
CUSIP
G9442G138
Shares Outstanding
631,761
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $17,858,732,000 | USD | 2025-09-30 | 20-F | 2026-01-29 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $11,557,563,000 | USD | 2025-09-30 | 20-F | 2026-01-29 |
| Gross Profit | $6,301,169,000 | USD | 2025-09-30 | 20-F | 2026-01-29 |
| Operating Expenses | $9,217,088,000 | USD | 2025-09-30 | 20-F | 2026-01-29 |
| Research & Development | $671,761,000 | USD | 2025-09-30 | 20-F | 2026-01-29 |
| Operating Income | $-2,915,919,000 | USD | 2025-09-30 | 20-F | 2026-01-29 |
| Net Income | $-3,672,055,000 | USD | 2025-09-30 | 20-F | 2026-01-29 |
| EPS (Basic) | $-8.06 | USD/shares | 2025-09-30 | 20-F | 2026-01-29 |
| EPS (Diluted) | $-8.06 | USD/shares | 2025-09-30 | 20-F | 2026-01-29 |